The global positive airway pressure devices market grew at a CAGR of around 8% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Positive airway pressure (PAP) therapy is widely used in the treatment of obstructive sleep apnea (OSA) and snoring. It is also utilized in respiratory ventilation to improve the oxygenation of patients in intensive care units (ICUs). PAP devices include straps to position the mask, a hose or tube to connect the mask to a motor and an air filter to purify the air entering the nostrils. Nowadays, automatic PAP devices that rely on proprietary algorithms to adjust the pressure delivered noninvasively are gaining traction worldwide to treat OSA at home.

The growing prevalence of hypertension, depression, diabetes and heart disorders is increasing the risk of developing OSA among individuals. This, in confluence with the availability of favorable reimbursement policies, represents one of the key factors escalating the demand for PAP devices across the globe. Apart from this, the introduction of portable, travel-friendly PAP devices is also bolstering the growth of the market. Furthermore, the leading manufacturers are developing and introducing compact and convenient product variants with improved noise reduction features. They are also providing discount offers on various products available through online retail channels. Moreover, various studies conducted by healthcare institutes are suggesting that continuous PAP devices can treat type 1 respiratory failure in patients diagnosed with the coronavirus disease (COVID-19). This, along with a shortage in the supply of mechanical ventilators, is anticipated to influence the market positively.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global positive airway pressure devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type and end user.

Breakup by Product Type:

Automatic Positive Airway Pressure (APAP) Devices
Continuous Positive Airway Pressure (CPAP) Devices
Bi-level Positive Airway Pressure (BiPAP) Devices

Breakup by End User:

Hospitals and Sleep Labs
Home Care
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being 3B Medical Inc., Apex Medical Corp., Compumedics Limited (D & DJ Burton Holdings Pty Ltd.), Drive Devilbiss Healthcare (Drive International LLC), Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Resmed Inc., Smiths Group Plc, Somnetics International Inc. and Vyaire Medical Inc.